Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Shares Outstanding (Diluted Average) (2020 - 2025)

PROCEPT BioRobotics has reported Shares Outstanding (Diluted Average) over the past 6 years, most recently at $55.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $55.5 million for Q4 2025, up 6.56% from a year ago — trailing twelve months through Dec 2025 was $55.5 million (up 6.56% YoY), and the annual figure for FY2025 was $55.5 million, up 6.56%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $55.5 million at PROCEPT BioRobotics, roughly flat from $55.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for PRCT hit a ceiling of $55.7 million in Q3 2025 and a floor of $4.8 million in Q1 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $46.2 million (2023), compared with a mean of $41.2 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): soared 807.97% in 2022 and later grew 1.58% in 2023.
  • PROCEPT BioRobotics' Shares Outstanding (Diluted Average) stood at $16.5 million in 2021, then skyrocketed by 169.42% to $44.4 million in 2022, then increased by 6.43% to $47.3 million in 2023, then grew by 10.31% to $52.1 million in 2024, then grew by 6.56% to $55.5 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $55.5 million (Q4 2025), $55.7 million (Q3 2025), and $55.2 million (Q2 2025) per Business Quant data.